nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP1A2—Carmustine—malignant glioma	0.42	0.569	CbGbCtD
Rimonabant—CYP3A4—Temozolomide—malignant glioma	0.317	0.43	CbGbCtD
Rimonabant—Paranoia—Carmustine—malignant glioma	0.0043	0.0506	CcSEcCtD
Rimonabant—Disturbance in attention—Temozolomide—malignant glioma	0.00327	0.0385	CcSEcCtD
Rimonabant—Gastroenteritis—Temozolomide—malignant glioma	0.00232	0.0273	CcSEcCtD
Rimonabant—Amnesia—Carmustine—malignant glioma	0.00226	0.0267	CcSEcCtD
Rimonabant—Hot flush—Temozolomide—malignant glioma	0.0022	0.0259	CcSEcCtD
Rimonabant—Amnesia—Temozolomide—malignant glioma	0.00219	0.0258	CcSEcCtD
Rimonabant—Menopausal symptoms—Temozolomide—malignant glioma	0.00218	0.0257	CcSEcCtD
Rimonabant—Mood swings—Temozolomide—malignant glioma	0.00195	0.0229	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00165	0.0194	CcSEcCtD
Rimonabant—Depression—Carmustine—malignant glioma	0.00163	0.0192	CcSEcCtD
Rimonabant—Infestation NOS—Temozolomide—malignant glioma	0.00158	0.0187	CcSEcCtD
Rimonabant—Infestation—Temozolomide—malignant glioma	0.00158	0.0187	CcSEcCtD
Rimonabant—Depression—Temozolomide—malignant glioma	0.00158	0.0186	CcSEcCtD
Rimonabant—Sinusitis—Temozolomide—malignant glioma	0.00149	0.0175	CcSEcCtD
Rimonabant—Hypoaesthesia—Carmustine—malignant glioma	0.00146	0.0172	CcSEcCtD
Rimonabant—Hallucination—Carmustine—malignant glioma	0.00146	0.0172	CcSEcCtD
Rimonabant—Connective tissue disorder—Carmustine—malignant glioma	0.00145	0.017	CcSEcCtD
Rimonabant—Hallucination—Temozolomide—malignant glioma	0.00141	0.0167	CcSEcCtD
Rimonabant—Hypoaesthesia—Temozolomide—malignant glioma	0.00141	0.0167	CcSEcCtD
Rimonabant—Connective tissue disorder—Temozolomide—malignant glioma	0.0014	0.0165	CcSEcCtD
Rimonabant—Angiopathy—Temozolomide—malignant glioma	0.00129	0.0152	CcSEcCtD
Rimonabant—Mental disorder—Carmustine—malignant glioma	0.00129	0.0152	CcSEcCtD
Rimonabant—Mediastinal disorder—Temozolomide—malignant glioma	0.00128	0.0151	CcSEcCtD
Rimonabant—Malnutrition—Carmustine—malignant glioma	0.00128	0.0151	CcSEcCtD
Rimonabant—Mental disorder—Temozolomide—malignant glioma	0.00125	0.0147	CcSEcCtD
Rimonabant—Malnutrition—Temozolomide—malignant glioma	0.00124	0.0146	CcSEcCtD
Rimonabant—Tremor—Carmustine—malignant glioma	0.0012	0.0141	CcSEcCtD
Rimonabant—Tremor—Temozolomide—malignant glioma	0.00116	0.0137	CcSEcCtD
Rimonabant—Convulsion—Carmustine—malignant glioma	0.00111	0.0131	CcSEcCtD
Rimonabant—Anxiety—Carmustine—malignant glioma	0.00109	0.0128	CcSEcCtD
Rimonabant—Convulsion—Temozolomide—malignant glioma	0.00107	0.0126	CcSEcCtD
Rimonabant—Anxiety—Temozolomide—malignant glioma	0.00105	0.0124	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00105	0.0123	CcSEcCtD
Rimonabant—Infection—Carmustine—malignant glioma	0.00104	0.0122	CcSEcCtD
Rimonabant—Dry mouth—Temozolomide—malignant glioma	0.00103	0.0121	CcSEcCtD
Rimonabant—Infection—Temozolomide—malignant glioma	0.001	0.0118	CcSEcCtD
Rimonabant—Anorexia—Carmustine—malignant glioma	0.000997	0.0117	CcSEcCtD
Rimonabant—Nervous system disorder—Temozolomide—malignant glioma	0.000991	0.0117	CcSEcCtD
Rimonabant—Skin disorder—Temozolomide—malignant glioma	0.000981	0.0116	CcSEcCtD
Rimonabant—Hyperhidrosis—Temozolomide—malignant glioma	0.000977	0.0115	CcSEcCtD
Rimonabant—Anorexia—Temozolomide—malignant glioma	0.000963	0.0113	CcSEcCtD
Rimonabant—Insomnia—Carmustine—malignant glioma	0.000946	0.0111	CcSEcCtD
Rimonabant—Paraesthesia—Carmustine—malignant glioma	0.000939	0.0111	CcSEcCtD
Rimonabant—Insomnia—Temozolomide—malignant glioma	0.000914	0.0108	CcSEcCtD
Rimonabant—Decreased appetite—Carmustine—malignant glioma	0.000909	0.0107	CcSEcCtD
Rimonabant—Paraesthesia—Temozolomide—malignant glioma	0.000907	0.0107	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Carmustine—malignant glioma	0.000903	0.0106	CcSEcCtD
Rimonabant—Decreased appetite—Temozolomide—malignant glioma	0.000878	0.0103	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000872	0.0103	CcSEcCtD
Rimonabant—Fatigue—Temozolomide—malignant glioma	0.000871	0.0103	CcSEcCtD
Rimonabant—Gastrointestinal pain—Carmustine—malignant glioma	0.000855	0.0101	CcSEcCtD
Rimonabant—Abdominal pain—Carmustine—malignant glioma	0.000826	0.00973	CcSEcCtD
Rimonabant—Gastrointestinal pain—Temozolomide—malignant glioma	0.000826	0.00973	CcSEcCtD
Rimonabant—Abdominal pain—Temozolomide—malignant glioma	0.000799	0.0094	CcSEcCtD
Rimonabant—Asthenia—Carmustine—malignant glioma	0.00075	0.00883	CcSEcCtD
Rimonabant—Asthenia—Temozolomide—malignant glioma	0.000725	0.00854	CcSEcCtD
Rimonabant—Diarrhoea—Carmustine—malignant glioma	0.000715	0.00842	CcSEcCtD
Rimonabant—Pruritus—Temozolomide—malignant glioma	0.000715	0.00842	CcSEcCtD
Rimonabant—Dizziness—Carmustine—malignant glioma	0.000691	0.00814	CcSEcCtD
Rimonabant—Diarrhoea—Temozolomide—malignant glioma	0.000691	0.00814	CcSEcCtD
Rimonabant—Dizziness—Temozolomide—malignant glioma	0.000668	0.00787	CcSEcCtD
Rimonabant—Vomiting—Carmustine—malignant glioma	0.000665	0.00783	CcSEcCtD
Rimonabant—Rash—Carmustine—malignant glioma	0.000659	0.00776	CcSEcCtD
Rimonabant—Dermatitis—Carmustine—malignant glioma	0.000659	0.00775	CcSEcCtD
Rimonabant—Headache—Carmustine—malignant glioma	0.000655	0.00771	CcSEcCtD
Rimonabant—Vomiting—Temozolomide—malignant glioma	0.000642	0.00756	CcSEcCtD
Rimonabant—Rash—Temozolomide—malignant glioma	0.000637	0.0075	CcSEcCtD
Rimonabant—Dermatitis—Temozolomide—malignant glioma	0.000636	0.00749	CcSEcCtD
Rimonabant—Headache—Temozolomide—malignant glioma	0.000633	0.00745	CcSEcCtD
Rimonabant—Nausea—Carmustine—malignant glioma	0.000621	0.00731	CcSEcCtD
Rimonabant—Nausea—Temozolomide—malignant glioma	0.0006	0.00707	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—PTPN11—malignant glioma	0.00016	0.000899	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.00016	0.000897	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000159	0.000896	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CB—malignant glioma	0.000159	0.000894	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH2—malignant glioma	0.000159	0.000893	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000159	0.000891	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PDGFRA—malignant glioma	0.000158	0.000889	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000158	0.000886	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000157	0.000883	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KNG1—malignant glioma	0.000156	0.000874	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SPP1—malignant glioma	0.000154	0.000863	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CXCL8—malignant glioma	0.000153	0.000859	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000152	0.000852	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AKT2—malignant glioma	0.000149	0.000838	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NTRK1—malignant glioma	0.000148	0.000833	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000147	0.000825	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL2—malignant glioma	0.000146	0.000821	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TERT—malignant glioma	0.000146	0.000818	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000144	0.000807	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000144	0.000807	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CD—malignant glioma	0.000143	0.000805	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000142	0.000799	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PDGFB—malignant glioma	0.000142	0.000798	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FGFR1—malignant glioma	0.000141	0.000794	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HIF1A—malignant glioma	0.000139	0.000782	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MMP3—malignant glioma	0.000138	0.000775	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—RTEL1—malignant glioma	0.000138	0.000774	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000138	0.000772	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000137	0.000769	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000137	0.000769	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CDKN2B—malignant glioma	0.000137	0.000768	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTP1—malignant glioma	0.000136	0.000765	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000136	0.000763	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CAV1—malignant glioma	0.000135	0.000757	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	0.000134	0.000755	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KDR—malignant glioma	0.000133	0.000748	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTK2—malignant glioma	0.000133	0.000746	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCL8—malignant glioma	0.000132	0.000742	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HES1—malignant glioma	0.00013	0.000733	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NCOR1—malignant glioma	0.00013	0.000728	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FN1—malignant glioma	0.000128	0.00072	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—F2—malignant glioma	0.000128	0.00072	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—RAF1—malignant glioma	0.000128	0.000718	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—BAD—malignant glioma	0.000127	0.000712	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—IL2—malignant glioma	0.000126	0.000709	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOTCH1—malignant glioma	0.000125	0.000705	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CB—malignant glioma	0.000125	0.000701	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PDGFRA—malignant glioma	0.000124	0.000697	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CD80—malignant glioma	0.000123	0.00069	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—APC—malignant glioma	0.000123	0.000689	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CG—malignant glioma	0.000123	0.000689	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGF—malignant glioma	0.000121	0.000681	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTPN11—malignant glioma	0.000121	0.000677	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SPP1—malignant glioma	0.000121	0.000677	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CXCL8—malignant glioma	0.00012	0.000674	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—BRAF—malignant glioma	0.000115	0.000648	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000115	0.000647	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL2—malignant glioma	0.000115	0.000644	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TERT—malignant glioma	0.000114	0.000642	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT2—malignant glioma	0.000112	0.000631	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EGFR—malignant glioma	0.000112	0.000628	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PDGFB—malignant glioma	0.000112	0.000627	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000111	0.000626	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FGFR1—malignant glioma	0.000111	0.000623	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HIF1A—malignant glioma	0.000109	0.000614	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CD—malignant glioma	0.000108	0.000606	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CA—malignant glioma	0.000107	0.0006	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000106	0.000597	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CAV1—malignant glioma	0.000106	0.000594	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—KRAS—malignant glioma	0.000106	0.000593	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000105	0.000591	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KDR—malignant glioma	0.000105	0.000587	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000104	0.000583	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FGF2—malignant glioma	0.000103	0.00058	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—F2—malignant glioma	0.000101	0.000565	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FN1—malignant glioma	0.000101	0.000565	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—BAD—malignant glioma	9.94e-05	0.000558	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH1—malignant glioma	9.85e-05	0.000553	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	9.85e-05	0.000553	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CA—malignant glioma	9.7e-05	0.000545	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MDM2—malignant glioma	9.66e-05	0.000543	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CD80—malignant glioma	9.65e-05	0.000542	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RAF1—malignant glioma	9.63e-05	0.000541	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CG—malignant glioma	9.63e-05	0.000541	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—APC—malignant glioma	9.63e-05	0.000541	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ERBB2—malignant glioma	9.53e-05	0.000535	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	9.53e-05	0.000535	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGF—malignant glioma	9.52e-05	0.000535	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTPN11—malignant glioma	9.46e-05	0.000531	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CB—malignant glioma	9.4e-05	0.000528	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—COX8A—malignant glioma	9.34e-05	0.000525	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—COX8A—malignant glioma	9.26e-05	0.00052	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—BRAF—malignant glioma	9.05e-05	0.000508	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCL8—malignant glioma	9.04e-05	0.000507	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT2—malignant glioma	8.81e-05	0.000495	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EGFR—malignant glioma	8.77e-05	0.000493	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—AKT1—malignant glioma	8.73e-05	0.00049	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CASP3—malignant glioma	8.65e-05	0.000486	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL2—malignant glioma	8.64e-05	0.000485	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CD—malignant glioma	8.46e-05	0.000475	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CA—malignant glioma	8.38e-05	0.000471	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—KRAS—malignant glioma	8.29e-05	0.000465	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	8.28e-05	0.000465	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MMP9—malignant glioma	8.17e-05	0.000459	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTEN—malignant glioma	8.13e-05	0.000456	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FGF2—malignant glioma	8.1e-05	0.000455	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ASMT—malignant glioma	7.94e-05	0.000446	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—AKT1—malignant glioma	7.93e-05	0.000445	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—COX8A—malignant glioma	7.91e-05	0.000444	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ASMT—malignant glioma	7.87e-05	0.000442	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	7.7e-05	0.000432	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CA—malignant glioma	7.61e-05	0.000428	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MDM2—malignant glioma	7.58e-05	0.000426	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RAF1—malignant glioma	7.56e-05	0.000424	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ERBB2—malignant glioma	7.48e-05	0.00042	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—BCAN—malignant glioma	7.47e-05	0.000419	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—BCAN—malignant glioma	7.4e-05	0.000416	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CB—malignant glioma	7.38e-05	0.000414	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VEGFA—malignant glioma	7.34e-05	0.000412	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—STAT3—malignant glioma	7.27e-05	0.000408	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL8—malignant glioma	7.09e-05	0.000398	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	7.07e-05	0.000397	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AKT1—malignant glioma	6.85e-05	0.000385	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CASP3—malignant glioma	6.79e-05	0.000381	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—malignant glioma	6.78e-05	0.000381	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—malignant glioma	6.75e-05	0.000379	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ASMT—malignant glioma	6.73e-05	0.000378	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGFR—malignant glioma	6.6e-05	0.000371	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.58e-05	0.000369	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MMP9—malignant glioma	6.41e-05	0.00036	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTEN—malignant glioma	6.38e-05	0.000358	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—BCAN—malignant glioma	6.33e-05	0.000355	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KRAS—malignant glioma	6.24e-05	0.00035	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AKT1—malignant glioma	6.22e-05	0.000349	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—COX8A—malignant glioma	6.11e-05	0.000343	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—IDH2—malignant glioma	6.02e-05	0.000338	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—IDH2—malignant glioma	5.97e-05	0.000335	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—malignant glioma	5.76e-05	0.000323	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CA—malignant glioma	5.73e-05	0.000322	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT3—malignant glioma	5.7e-05	0.00032	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2B6—malignant glioma	5.66e-05	0.000318	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.63e-05	0.000316	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2B6—malignant glioma	5.61e-05	0.000315	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—malignant glioma	5.55e-05	0.000311	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—malignant glioma	5.3e-05	0.000298	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ASMT—malignant glioma	5.19e-05	0.000292	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGFR—malignant glioma	5.18e-05	0.000291	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—IDH1—malignant glioma	5.18e-05	0.000291	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—IDH1—malignant glioma	5.13e-05	0.000288	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—IDH2—malignant glioma	5.1e-05	0.000286	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SPHK1—malignant glioma	5.01e-05	0.000281	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SPHK1—malignant glioma	4.97e-05	0.000279	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2C18—malignant glioma	4.91e-05	0.000276	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KRAS—malignant glioma	4.9e-05	0.000275	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—BCAN—malignant glioma	4.88e-05	0.000274	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2C18—malignant glioma	4.86e-05	0.000273	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.81e-05	0.00027	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2B6—malignant glioma	4.79e-05	0.000269	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT1—malignant glioma	4.68e-05	0.000263	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.59e-05	0.000258	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—malignant glioma	4.5e-05	0.000253	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—IDH1—malignant glioma	4.39e-05	0.000246	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—malignant glioma	4.35e-05	0.000244	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SPHK1—malignant glioma	4.24e-05	0.000238	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.18e-05	0.000235	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2C18—malignant glioma	4.16e-05	0.000233	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.03e-05	0.000226	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTT1—malignant glioma	3.97e-05	0.000223	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—IDH2—malignant glioma	3.94e-05	0.000221	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTT1—malignant glioma	3.93e-05	0.000221	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.92e-05	0.00022	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS1—malignant glioma	3.72e-05	0.000209	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.7e-05	0.000208	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS1—malignant glioma	3.69e-05	0.000207	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—malignant glioma	3.67e-05	0.000206	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.67e-05	0.000206	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.57e-05	0.000201	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—BCHE—malignant glioma	3.46e-05	0.000194	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.45e-05	0.000194	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—BCHE—malignant glioma	3.43e-05	0.000192	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC5A5—malignant glioma	3.41e-05	0.000192	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC5A5—malignant glioma	3.39e-05	0.00019	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—IDH1—malignant glioma	3.38e-05	0.00019	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTT1—malignant glioma	3.36e-05	0.000189	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SPHK1—malignant glioma	3.27e-05	0.000184	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.21e-05	0.00018	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.2e-05	0.00018	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.17e-05	0.000178	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS1—malignant glioma	3.15e-05	0.000177	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.14e-05	0.000176	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—BCHE—malignant glioma	2.93e-05	0.000164	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.89e-05	0.000162	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.77e-05	0.000155	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTP1—malignant glioma	2.75e-05	0.000154	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.74e-05	0.000154	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTP1—malignant glioma	2.73e-05	0.000153	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.71e-05	0.000152	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CAT—malignant glioma	2.68e-05	0.00015	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CAT—malignant glioma	2.65e-05	0.000149	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTT1—malignant glioma	2.59e-05	0.000146	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOR1—malignant glioma	2.53e-05	0.000142	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOR1—malignant glioma	2.51e-05	0.000141	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS1—malignant glioma	2.43e-05	0.000137	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.36e-05	0.000133	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTP1—malignant glioma	2.33e-05	0.000131	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CAT—malignant glioma	2.27e-05	0.000127	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—BCHE—malignant glioma	2.26e-05	0.000127	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.23e-05	0.000125	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOR1—malignant glioma	2.14e-05	0.00012	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CAV1—malignant glioma	2.06e-05	0.000116	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CAV1—malignant glioma	2.04e-05	0.000115	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.95e-05	0.00011	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.88e-05	0.000105	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.86e-05	0.000105	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPARG—malignant glioma	1.81e-05	0.000102	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTP1—malignant glioma	1.8e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPARG—malignant glioma	1.8e-05	0.000101	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CAT—malignant glioma	1.75e-05	9.83e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CAV1—malignant glioma	1.75e-05	9.8e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.67e-05	9.37e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOR1—malignant glioma	1.65e-05	9.28e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.65e-05	9.27e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.64e-05	9.19e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.59e-05	8.93e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPARG—malignant glioma	1.53e-05	8.62e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.44e-05	8.08e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.43e-05	8.01e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—malignant glioma	1.43e-05	8e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—malignant glioma	1.41e-05	7.93e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.4e-05	7.85e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CAV1—malignant glioma	1.35e-05	7.57e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTEN—malignant glioma	1.24e-05	6.98e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTEN—malignant glioma	1.23e-05	6.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.23e-05	6.89e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.22e-05	6.84e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—malignant glioma	1.21e-05	6.78e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARG—malignant glioma	1.18e-05	6.65e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.08e-05	6.06e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTEN—malignant glioma	1.05e-05	5.91e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CB—malignant glioma	9.4e-06	5.28e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—malignant glioma	9.32e-06	5.23e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—malignant glioma	8.77e-06	4.92e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—malignant glioma	8.69e-06	4.88e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTEN—malignant glioma	8.13e-06	4.56e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—malignant glioma	7.43e-06	4.17e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—malignant glioma	7.16e-06	4.02e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—malignant glioma	7.1e-06	3.99e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—malignant glioma	6.07e-06	3.41e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.73e-06	3.22e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—malignant glioma	4.68e-06	2.63e-05	CbGpPWpGaD
